Subgroup identification of targeted therapy effects on biomarker for time to event data
{{output}}
Background: The initiation biomarker-driven trials have revolutionized oncology drug development by challenging the traditional phased approach and introducing basket studies. Notable successes in non-small cell lung cancer (NSCL... ...
